HCPCS J2353

Injection, octreotide, depot form for intramuscular injection, 1 mg

HCPCS Code: J2353: The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J2353 identifies the type of service or supply used while any of the 6 NDC codes below could be used to specify the exact drug used.
Short Description: Octreotide injection, depot
Long Description: Injection, octreotide, depot form for intramuscular injection, 1 mg
Pricing Indicator: Drugs
Multiple Pricing Indicator: Not applicable as HCPCS priced under one methodology
Coverage Description: Carrier judgment
BETOS Type of Service: Other drugs
Medicare Payment Limit: $212.20
Medicare Co-Insurance Percentage: 20.000%
HCPCS Classification: List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0078-0811	Sandostatin Lar Depot	Octreotide Acetate	Kit		Novartis Pharmaceuticals Corporation	ACTIVE
0078-0818	Sandostatin Lar Depot	Octreotide Acetate	Kit		Novartis Pharmaceuticals Corporation	ACTIVE
0078-0825	Sandostatin Lar Depot	Octreotide Acetate	Kit		Novartis Pharmaceuticals Corporation	ACTIVE
0480-9257	Octreotide Acetate	Octreotide Acetate	Kit	Intramuscular	Teva Pharmaceuticals, Inc.	ACTIVE
0480-9259	Octreotide Acetate	Octreotide Acetate	Kit	Intramuscular	Teva Pharmaceuticals, Inc.	ACTIVE
0480-9262	Octreotide Acetate	Octreotide Acetate	Kit	Intramuscular	Teva Pharmaceuticals, Inc.	ACTIVE